Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Generated: June 18, 2018

DrugPatentWatch Database Preview

Mayne Pharma Inc Company Profile

« Back to Dashboard

What is the competitive landscape for MAYNE PHARMA INC, and what generic and branded alternatives to MAYNE PHARMA INC drugs are available?

MAYNE PHARMA INC has nineteen approved drugs.

Summary for Mayne Pharma Inc

US Patents:	0
Tradenames:	17
Ingredients:	17
NDAs:	19

Drugs and US Patents for Mayne Pharma Inc

+ Get email alerts for changes to this table

This preview shows a limited data set. Subscribe for full access, or try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Mayne Pharma Inc	OXYCODONE AND ACETAMINOPHEN	acetaminophen; oxycodone hydrochloride	TABLET;ORAL	090177-005	Oct 20, 2008		DISCN	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Mayne Pharma Inc	DOXYCYCLINE HYCLATE	doxycycline hyclate	TABLET;ORAL	208765-001	Jun 14, 2017	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Mayne Pharma Inc	DOXYCYCLINE	doxycycline	CAPSULE;ORAL	209396-001	Sep 29, 2017	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Mayne Pharma Inc	BUTALBITAL, ASPIRIN, CAFFEINE AND CODEINE PHOSPHATE	aspirin; butalbital; caffeine; codeine phosphate	CAPSULE;ORAL	203335-001	Oct 30, 2015	AB	RX	No	No		➤ Try a Free Trial				➤ Try a Free Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army

Moodys

Cerilliant

Merck

Federal Trade Commission

Queensland Health

Medtronic

UBS

Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.